CAR-T transformed blood cancer care, but solid and brain tumors demand different delivery, manufacturing, and safety strategies to work.
|Articles|August 26, 2019
High-Throughput Automated pH Measurements for Biologics Formulations
Author(s)Unchained Labs
Measuring pH in high throughput is a tedious task when it’s a 96-well plate. Measure pH with precision and accuracy with an improved four-channel pH arm from Unchained Labs.
Related to this article
AAPS PharmSci 360 2026 in New Orleans centered on auditable AI, modeling-guided formulation, oral peptide delivery, high-concentration antibody suspensions, and the push toward $10-per-gram monoclonal antibodies.
Samsung Biologics' pending PolyPeptide deal adds peptide API manufacturing, including GLP-1 supply, to its antibody and ADC CDMO services.
The deal gives Fresenius options on biosimilars spanning monoclonal and bispecific antibodies, ADCs, and fusion proteins, starting with polatuzumab vedotin and teprotumumab, and could expand its portfolio from 29 to 66 molecules.
FDA set a May 1, 2027 target date for AMT-130, a one-time gene therapy that silences the huntingtin gene, and plans an advisory committee meeting.
Inovio reports that Voceryq spared 27% of adults with recurrent respiratory papillomatosis from surgery for 12 months in a 26-patient efficacy group.
Three case studies show how automated Raman plate reading can triage samples before chromatography in bioprocess development.
This year’s AAPS PharmSci 360 highlighted AI transparency, computer modeling in formulation, oral peptide delivery, and new business models.
Trending on BioPharm International
1
Fresenius and WuXi Biologics Sign Exclusive Agreement Covering Up to 37 Biosimilar Candidates
2
Drug Digest: Reshoring Manufacturing and Securing Cold-Chain Supply for Biopharma
3
Samsung Biologics Secures 97.66% of PolyPeptide Shares in Tender Offer
4
Resolving the Speed-Specificity Trade-Off in Biopharma High-Throughput Screening
5